Logo image of BAKKA.OL

BAKKAFROST P/F (BAKKA.OL) Stock Fundamental Analysis

Europe - OSL:BAKKA - FO0000000179 - Common Stock

480.8 NOK
-2.2 (-0.46%)
Last: 10/17/2025, 4:25:31 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BAKKA. BAKKA was compared to 59 industry peers in the Food Products industry. Both the profitability and the financial health of BAKKA get a neutral evaluation. Nothing too spectacular is happening here. BAKKA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BAKKA had positive earnings in the past year.
In the past year BAKKA had a positive cash flow from operations.
In the past 5 years BAKKA has always been profitable.
BAKKA had a positive operating cash flow in each of the past 5 years.
BAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFBAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B -3B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.30%, BAKKA is doing worse than 71.19% of the companies in the same industry.
The Return On Equity of BAKKA (2.19%) is worse than 76.27% of its industry peers.
BAKKA's Return On Invested Capital of 4.10% is in line compared to the rest of the industry. BAKKA outperforms 42.37% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BAKKA is in line with the industry average of 6.79%.
Industry RankSector Rank
ROA 1.3%
ROE 2.19%
ROIC 4.1%
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
BAKKA.OL Yearly ROA, ROE, ROICBAKKA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

BAKKA's Profit Margin of 3.49% is in line compared to the rest of the industry. BAKKA outperforms 49.15% of its industry peers.
In the last couple of years the Profit Margin of BAKKA has declined.
With an excellent Operating Margin value of 13.65%, BAKKA belongs to the best of the industry, outperforming 81.36% of the companies in the same industry.
BAKKA's Operating Margin has declined in the last couple of years.
BAKKA has a better Gross Margin (71.02%) than 98.31% of its industry peers.
In the last couple of years the Gross Margin of BAKKA has remained more or less at the same level.
Industry RankSector Rank
OM 13.65%
PM (TTM) 3.49%
GM 71.02%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
BAKKA.OL Yearly Profit, Operating, Gross MarginsBAKKA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

BAKKA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BAKKA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, BAKKA has more shares outstanding
Compared to 1 year ago, BAKKA has an improved debt to assets ratio.
BAKKA.OL Yearly Shares OutstandingBAKKA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BAKKA.OL Yearly Total Debt VS Total AssetsBAKKA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.85 indicates that BAKKA is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of BAKKA (2.85) is better than 71.19% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that BAKKA is not too dependend on debt financing.
The Debt to Equity ratio of BAKKA (0.47) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z 2.85
ROIC/WACC0.51
WACC8.11%
BAKKA.OL Yearly LT Debt VS Equity VS FCFBAKKA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

BAKKA has a Current Ratio of 12.90. This indicates that BAKKA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BAKKA (12.90) is better than 98.31% of its industry peers.
A Quick Ratio of 2.27 indicates that BAKKA has no problem at all paying its short term obligations.
The Quick ratio of BAKKA (2.27) is better than 91.53% of its industry peers.
Industry RankSector Rank
Current Ratio 12.9
Quick Ratio 2.27
BAKKA.OL Yearly Current Assets VS Current LiabilitesBAKKA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

The earnings per share for BAKKA have decreased strongly by -46.96% in the last year.
BAKKA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.36% yearly.
BAKKA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.08%.
BAKKA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.21% yearly.
EPS 1Y (TTM)-46.96%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%-102.02%
Revenue 1Y (TTM)-15.08%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-23.83%

3.2 Future

BAKKA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.41% yearly.
Based on estimates for the next years, BAKKA will show a small growth in Revenue. The Revenue will grow by 7.81% on average per year.
EPS Next Y-29.04%
EPS Next 2Y7.79%
EPS Next 3Y14.41%
EPS Next 5YN/A
Revenue Next Year-3.84%
Revenue Next 2Y6.53%
Revenue Next 3Y7.81%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BAKKA.OL Yearly Revenue VS EstimatesBAKKA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
BAKKA.OL Yearly EPS VS EstimatesBAKKA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15 20 25

2

4. Valuation

4.1 Price/Earnings Ratio

BAKKA is valuated quite expensively with a Price/Earnings ratio of 30.22.
BAKKA's Price/Earnings ratio is a bit more expensive when compared to the industry. BAKKA is more expensive than 69.49% of the companies in the same industry.
When comparing the Price/Earnings ratio of BAKKA to the average of the S&P500 Index (27.29), we can say BAKKA is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 14.28, the valuation of BAKKA can be described as correct.
BAKKA's Price/Forward Earnings is on the same level as the industry average.
BAKKA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.85.
Industry RankSector Rank
PE 30.22
Fwd PE 14.28
BAKKA.OL Price Earnings VS Forward Price EarningsBAKKA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BAKKA indicates a slightly more expensive valuation: BAKKA is more expensive than 64.41% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.01
BAKKA.OL Per share dataBAKKA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

A more expensive valuation may be justified as BAKKA's earnings are expected to grow with 14.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.79%
EPS Next 3Y14.41%

3

5. Dividend

5.1 Amount

BAKKA has a Yearly Dividend Yield of 2.78%. Purely for dividend investing, there may be better candidates out there.
BAKKA's Dividend Yield is comparable with the industry average which is at 3.36.
BAKKA's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

The dividend of BAKKA has a limited annual growth rate of 3.15%.
Dividend Growth(5Y)3.15%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

219.43% of the earnings are spent on dividend by BAKKA. This is not a sustainable payout ratio.
The dividend of BAKKA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP219.43%
EPS Next 2Y7.79%
EPS Next 3Y14.41%
BAKKA.OL Yearly Income VS Free CF VS DividendBAKKA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
BAKKA.OL Dividend Payout.BAKKA.OL Dividend Payout, showing the Payout Ratio.BAKKA.OL Dividend Payout.PayoutRetained Earnings

BAKKAFROST P/F

OSL:BAKKA (10/17/2025, 4:25:31 PM)

480.8

-2.2 (-0.46%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-26 2025-08-26/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners55.36%
Inst Owner ChangeN/A
Ins Owners16.06%
Ins Owner ChangeN/A
Market Cap28.55B
Analysts74.44
Price Target498.91 (3.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend13.6
Dividend Growth(5Y)3.15%
DP219.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.41%
Min EPS beat(2)-106.11%
Max EPS beat(2)-14.72%
EPS beat(4)0
Avg EPS beat(4)-43.68%
Min EPS beat(4)-106.11%
Max EPS beat(4)-2.8%
EPS beat(8)2
Avg EPS beat(8)-25.32%
EPS beat(12)3
Avg EPS beat(12)-21.81%
EPS beat(16)3
Avg EPS beat(16)-24.75%
Revenue beat(2)0
Avg Revenue beat(2)-17.2%
Min Revenue beat(2)-21.74%
Max Revenue beat(2)-12.67%
Revenue beat(4)0
Avg Revenue beat(4)-16.42%
Min Revenue beat(4)-21.74%
Max Revenue beat(4)-12.34%
Revenue beat(8)1
Avg Revenue beat(8)-10.61%
Revenue beat(12)4
Avg Revenue beat(12)-4.72%
Revenue beat(16)5
Avg Revenue beat(16)-5.03%
PT rev (1m)-5.09%
PT rev (3m)-15.46%
EPS NQ rev (1m)13.75%
EPS NQ rev (3m)-42.65%
EPS NY rev (1m)-7.56%
EPS NY rev (3m)-40.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.03%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-5.38%
Valuation
Industry RankSector Rank
PE 30.22
Fwd PE 14.28
P/S 2.78
P/FCF N/A
P/OCF 17.66
P/B 1.74
P/tB 3.07
EV/EBITDA 14.01
EPS(TTM)15.91
EY3.31%
EPS(NY)33.68
Fwd EY7%
FCF(TTM)-1.68
FCFYN/A
OCF(TTM)27.23
OCFY5.66%
SpS172.85
BVpS275.95
TBVpS156.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.3%
ROE 2.19%
ROCE 5.17%
ROIC 4.1%
ROICexc 4.15%
ROICexgc 5.64%
OM 13.65%
PM (TTM) 3.49%
GM 71.02%
FCFM N/A
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
ROICexc(3y)6.94%
ROICexc(5y)5.73%
ROICexgc(3y)9.65%
ROICexgc(5y)8.22%
ROCE(3y)8.44%
ROCE(5y)6.96%
ROICexcg growth 3Y13.09%
ROICexcg growth 5Y-10.07%
ROICexc growth 3Y16.55%
ROICexc growth 5Y-6.46%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA 2.98
Cap/Depr 145.81%
Cap/Sales 16.72%
Interest Coverage 250
Cash Conversion 62.7%
Profit Quality N/A
Current Ratio 12.9
Quick Ratio 2.27
Altman-Z 2.85
F-Score5
WACC8.11%
ROIC/WACC0.51
Cap/Depr(3y)180.8%
Cap/Depr(5y)188.01%
Cap/Sales(3y)15.4%
Cap/Sales(5y)16.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.96%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%-102.02%
EPS Next Y-29.04%
EPS Next 2Y7.79%
EPS Next 3Y14.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.08%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-23.83%
Revenue Next Year-3.84%
Revenue Next 2Y6.53%
Revenue Next 3Y7.81%
Revenue Next 5YN/A
EBIT growth 1Y-38.14%
EBIT growth 3Y25.01%
EBIT growth 5Y1.6%
EBIT Next Year23.25%
EBIT Next 3Y28.27%
EBIT Next 5YN/A
FCF growth 1Y-138.63%
FCF growth 3Y431.02%
FCF growth 5YN/A
OCF growth 1Y-29.4%
OCF growth 3Y27.94%
OCF growth 5Y17.84%